MX9303124A - Compuestos organicos de benzodiazepina, procedimiento para su preparacion y formulaciones farmaceuticas que los contienen. - Google Patents
Compuestos organicos de benzodiazepina, procedimiento para su preparacion y formulaciones farmaceuticas que los contienen.Info
- Publication number
- MX9303124A MX9303124A MX9303124A MX9303124A MX9303124A MX 9303124 A MX9303124 A MX 9303124A MX 9303124 A MX9303124 A MX 9303124A MX 9303124 A MX9303124 A MX 9303124A MX 9303124 A MX9303124 A MX 9303124A
- Authority
- MX
- Mexico
- Prior art keywords
- benzodiazepine
- procedure
- contain
- preparation
- organic compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
La presente invención describe compuestos farmacéuticos de la fórmula (I); en la cual R1 es hidrógeno o halo, y R2 es alquilo de 1 a 10 átomos de carbono, alquenilo de 2 a 10 átomos de carbono, alquinilo de 2 a 10 átomos de carbono, cicloalquilo de 3 a 6 átomos de carbono substituido opcionalmente por 1 a 3 grupos, alquilo de 1 a 4 átomos de carbono, cicloalquilo de 3 a 6 átomos de carbono-alquilo de 1 a 4 átomos de carbono, en el cual el grupo cicloalquilo está opcionalmente substituído por 1 a 3 grupos de alquilo de 1 a 4 átomos de carbono, o fenilo substituído opcionalmente-alquilo de 1 a 4 átomos de carbono; o una sal de los mismos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929211379A GB9211379D0 (en) | 1992-05-29 | 1992-05-29 | Pharmaceutical compounds |
GB939309025A GB9309025D0 (en) | 1993-04-30 | 1993-04-30 | Pharmaceutical compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9303124A true MX9303124A (es) | 1993-11-01 |
Family
ID=26300951
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9303124A MX9303124A (es) | 1992-05-29 | 1993-05-27 | Compuestos organicos de benzodiazepina, procedimiento para su preparacion y formulaciones farmaceuticas que los contienen. |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP0582368B1 (es) |
JP (1) | JP3219541B2 (es) |
CN (1) | CN1043994C (es) |
AT (1) | ATE198891T1 (es) |
AU (1) | AU668159B2 (es) |
CA (1) | CA2097016A1 (es) |
CZ (1) | CZ282783B6 (es) |
DE (1) | DE69329887T2 (es) |
DK (1) | DK0582368T3 (es) |
ES (1) | ES2153373T3 (es) |
FI (1) | FI101538B1 (es) |
GR (1) | GR3035587T3 (es) |
HU (1) | HU218278B (es) |
IL (1) | IL105827A (es) |
MX (1) | MX9303124A (es) |
MY (1) | MY109943A (es) |
NO (1) | NO305125B1 (es) |
NZ (1) | NZ247703A (es) |
PT (1) | PT582368E (es) |
RU (1) | RU2125574C1 (es) |
TW (1) | TW268005B (es) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5457101A (en) * | 1994-06-03 | 1995-10-10 | Eli Lilly And Company | Thieno[1,5]benzoidiazepine use |
US5574028A (en) * | 1994-10-31 | 1996-11-12 | Eli Lilly And Company | Method for treating anxiety |
EG23659A (en) * | 1995-03-24 | 2007-03-26 | Lilly Co Eli | Process and crystal forms of methyl-thieno-benzodiazepine |
CR5278A (es) * | 1995-03-24 | 1996-07-04 | Lilly Co Eli | Formulacion oral de 2-metil-tieno-benzodiacepina |
EG24221A (en) * | 1995-03-24 | 2008-11-10 | Lilly Co Eli | Process for preparing olanzapine |
US5891461A (en) * | 1995-09-14 | 1999-04-06 | Cygnus, Inc. | Transdermal administration of olanzapine |
IL126203A (en) * | 1996-03-25 | 2002-12-01 | Lilly Co Eli | A synergistic painkiller that contains olenzapine and another painkiller |
CN1219878A (zh) * | 1996-03-25 | 1999-06-16 | 伊莱利利公司 | 治疗疼痛的方法 |
EA000769B1 (ru) * | 1996-03-25 | 2000-04-24 | Эли Лилли Энд Компани | Способ лечения при боли, вызванной мигренью |
KR100516088B1 (ko) * | 1996-09-23 | 2005-09-22 | 일라이 릴리 앤드 캄파니 | 올란자핀 이수화물 d |
ZA978515B (en) * | 1996-09-23 | 1999-03-23 | Lilly Co Eli | Intermediates and process for preparing olanzapine |
JP2001501207A (ja) * | 1996-09-24 | 2001-01-30 | イーライ・リリー・アンド・カンパニー | コーティングされた粒子製剤 |
EP3556759B1 (en) | 2012-08-21 | 2023-11-29 | Janssen Pharmaceutica NV | Haptens of paliperidone |
AU2013305938B2 (en) | 2012-08-21 | 2017-08-17 | Saladax Biomedical Inc. | Antibodies to paliperidone haptens and use thereof |
CA2882490A1 (en) | 2012-08-21 | 2014-02-27 | Ortho-Clinical Diagnostics, Inc. | Antibodies to paliperidone and use thereof |
CA2882615C (en) | 2012-08-21 | 2019-07-09 | Ortho-Clinical Diagnostics, Inc. | Antibodies to quetiapine and use thereof |
PT3663317T (pt) | 2012-08-21 | 2023-01-23 | Janssen Pharmaceutica Nv | Anticorpos para haptenos de quetiapina e sua utilização |
ES2701062T3 (es) | 2012-08-21 | 2019-02-20 | Janssen Pharmaceutica Nv | Haptenos de olanzapina |
EP3321254B1 (en) | 2012-08-21 | 2020-08-12 | Janssen Pharmaceutica NV | Haptens of aripiprazole and their use in immunoassays |
WO2014031656A1 (en) | 2012-08-21 | 2014-02-27 | Ortho-Clinical Diagnostics, Inc | Antibodies to olanzapine haptens and use thereof |
PT2888593T (pt) | 2012-08-21 | 2018-12-12 | Janssen Pharmaceutica Nv | Anticorpos contra risperidona e utilizações dos mesmos |
WO2014031662A2 (en) | 2012-08-21 | 2014-02-27 | Ortho-Clinical Diagnostics, Inc | Antibodies to olanzapine and use thereof |
JP6389176B2 (ja) | 2012-08-21 | 2018-09-12 | ヤンセン ファーマシューティカ エヌ.ベー. | アリピプラゾールハプテンに対する抗体及びその使用 |
JP6131500B2 (ja) | 2012-08-21 | 2017-05-24 | ヤンセン ファーマシューティカ エヌ.ベー. | リスペリドン及びパリペリドンのハプテン |
PL2888257T3 (pl) | 2012-08-21 | 2018-02-28 | Janssen Pharmaceutica Nv | Hapteny kwetiapiny do zastosowania w testach immunologicznych |
PL2888284T3 (pl) | 2012-08-21 | 2023-02-27 | Janssen Pharmaceutica Nv | Przeciwciała przeciwko haptenom rysperydonu i ich zastosowanie |
PL3354751T3 (pl) | 2012-08-21 | 2020-03-31 | Janssen Pharmaceutica Nv | Przeciwciała dla arypiprazolu i ich zastosowanie |
CN108368180B (zh) | 2015-12-17 | 2022-07-26 | 詹森药业有限公司 | 喹硫平的抗体及其用途 |
CN108431040B (zh) | 2015-12-17 | 2022-07-26 | 詹森药业有限公司 | 利培酮的抗体及其用途 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU629879A3 (ru) * | 1974-11-26 | 1978-10-25 | Лилли Индастриз Лимитед, (Фирма) | Способ получени тиено(1,5) бензодиазепинов или их солей |
DE2641378A1 (de) * | 1975-09-24 | 1977-04-07 | Sandoz Ag | Neue organische verbindungen, ihre verwendung und herstellung |
GB9009229D0 (en) * | 1990-04-25 | 1990-06-20 | Lilly Industries Ltd | Pharmaceutical compounds |
-
1993
- 1993-05-26 NO NO931917A patent/NO305125B1/no not_active IP Right Cessation
- 1993-05-26 DK DK93304102T patent/DK0582368T3/da active
- 1993-05-26 TW TW082104161A patent/TW268005B/zh active
- 1993-05-26 EP EP93304102A patent/EP0582368B1/en not_active Expired - Lifetime
- 1993-05-26 PT PT93304102T patent/PT582368E/pt unknown
- 1993-05-26 ES ES93304102T patent/ES2153373T3/es not_active Expired - Lifetime
- 1993-05-26 CA CA002097016A patent/CA2097016A1/en not_active Abandoned
- 1993-05-26 DE DE69329887T patent/DE69329887T2/de not_active Expired - Fee Related
- 1993-05-26 AU AU39807/93A patent/AU668159B2/en not_active Ceased
- 1993-05-26 NZ NZ247703A patent/NZ247703A/en unknown
- 1993-05-26 AT AT93304102T patent/ATE198891T1/de not_active IP Right Cessation
- 1993-05-27 MX MX9303124A patent/MX9303124A/es not_active IP Right Cessation
- 1993-05-28 CN CN93108212A patent/CN1043994C/zh not_active Expired - Fee Related
- 1993-05-28 CZ CZ931024A patent/CZ282783B6/cs not_active IP Right Cessation
- 1993-05-28 RU RU93005057A patent/RU2125574C1/ru active
- 1993-05-28 FI FI932445A patent/FI101538B1/fi active
- 1993-05-28 HU HU9301579A patent/HU218278B/hu not_active IP Right Cessation
- 1993-05-28 JP JP12642993A patent/JP3219541B2/ja not_active Expired - Fee Related
- 1993-05-28 MY MYPI93001036A patent/MY109943A/en unknown
- 1993-05-28 IL IL10582793A patent/IL105827A/xx not_active IP Right Cessation
-
2001
- 2001-03-15 GR GR20010400431T patent/GR3035587T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
RU2125574C1 (ru) | 1999-01-27 |
ES2153373T3 (es) | 2001-03-01 |
FI101538B (fi) | 1998-07-15 |
GR3035587T3 (en) | 2001-06-29 |
TW268005B (es) | 1996-01-11 |
JP3219541B2 (ja) | 2001-10-15 |
FI932445A0 (fi) | 1993-05-28 |
JPH0687862A (ja) | 1994-03-29 |
FI101538B1 (fi) | 1998-07-15 |
DK0582368T3 (da) | 2001-02-05 |
EP0582368A1 (en) | 1994-02-09 |
NO931917L (no) | 1993-11-30 |
HU218278B (en) | 2000-07-28 |
DE69329887D1 (de) | 2001-03-01 |
FI932445A (fi) | 1993-11-30 |
NO931917D0 (no) | 1993-05-26 |
CZ282783B6 (cs) | 1997-10-15 |
CN1085903A (zh) | 1994-04-27 |
MY109943A (en) | 1997-10-31 |
PT582368E (pt) | 2001-05-31 |
NZ247703A (en) | 1995-07-26 |
HUT66180A (en) | 1994-09-28 |
CN1043994C (zh) | 1999-07-07 |
IL105827A (en) | 1997-02-18 |
EP0582368B1 (en) | 2001-01-24 |
AU668159B2 (en) | 1996-04-26 |
CA2097016A1 (en) | 1993-11-30 |
HU9301579D0 (en) | 1993-09-28 |
AU3980793A (en) | 1993-12-02 |
NO305125B1 (no) | 1999-04-06 |
ATE198891T1 (de) | 2001-02-15 |
DE69329887T2 (de) | 2001-05-23 |
IL105827A0 (en) | 1993-09-22 |
CZ102493A3 (en) | 1993-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9303124A (es) | Compuestos organicos de benzodiazepina, procedimiento para su preparacion y formulaciones farmaceuticas que los contienen. | |
ES2081187T3 (es) | Nuevas naftil-alquil-aminas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen. | |
ES2123039T3 (es) | Nuevas 3-(hidroxi-bencilidenil)-indolin-2-onas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen. | |
MX9304756A (es) | 9-[(glicilo substituido)amido]-6-desmetil-6-desoxitetraciclinas, metodo para su produccion y composiciones farmaceuticas que las contienen. | |
ES2143526T3 (es) | Derivados de amida que tienen actividad antihipercolesterolemica, su preparacion y sus usos terapeuticos. | |
ES2079719T3 (es) | Derivados de amidinofenilalanina, procedimiento para su preparacion, su utilizacion y agentes que los contienen en calidad de anticoagulantes. | |
ES2118203T3 (es) | Nuevos derivados benzopiranicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen. | |
ES2062443T3 (es) | Nuevos derivados peptidicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
ES528561A0 (es) | Un procedimiento para la preparacion de compuestos nitro alifaticos | |
ES2103440T3 (es) | Nuevas amidas y sulfonamidas naftalenicas, procedimiento de preparacion y composiciones farmaceuticas que las contienen. | |
MX9201279A (es) | Derivados de 1-fenil-3-aza bi ciclo alquil-imidazolidin-2-onas, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
NO168428C (no) | Analogifremgangsmaate ved fremstilling av et terapeutisk aktivt pyrrolidonderivat | |
ES2077473T3 (es) | Nuevos compuestos tiocromanicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen. | |
ES2122221T3 (es) | Compuestos terapeuticos adecuados para el tratamiento de enfermedades conectadas con la deficiencia de glutation, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
MX9203577A (es) | Nuevos derivados de sinergistinas y composiciones farmaceuticas que los contienen. | |
SV1998000013A (es) | Derivados de 5-aroilnaftaleno ref.-ran 4070\115 | |
MX9307874A (es) | Compuestos de amida ciclica, procedimiento para supreparacion y su uso como herbicidas. | |
MX9303392A (es) | Derivados de imidazo benzoxazin-1-ona substituidos y proceso para su preparacion. | |
BR9305752A (pt) | Composto composiçao farmaceutica e processo para a preparaçao de um composto de derivados alquila da trazodona | |
ES2076054T3 (es) | Nuevas amino-alquil-cromonas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen. | |
ES2065192T3 (es) | Nuevos nicotinatos de diacil-glicerol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
ES2132429T3 (es) | Disacaridos de antraciclina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
TW275629B (es) | ||
ES2103553T3 (es) | Nuevos cicloalquil-(b)-indoles, su procedimiento de preparacion y composiciones farmaceuticas que los contienen. | |
ES2123038T3 (es) | Nuevos derivados pirrolo-tieno-pirazinicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration | ||
MM | Annulment or lapse due to non-payment of fees |